AU2003242506A1 - Tf antagonist - Google Patents

Tf antagonist

Info

Publication number
AU2003242506A1
AU2003242506A1 AU2003242506A AU2003242506A AU2003242506A1 AU 2003242506 A1 AU2003242506 A1 AU 2003242506A1 AU 2003242506 A AU2003242506 A AU 2003242506A AU 2003242506 A AU2003242506 A AU 2003242506A AU 2003242506 A1 AU2003242506 A1 AU 2003242506A1
Authority
AU
Australia
Prior art keywords
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003242506A
Inventor
Soren E. Bjorn
Lars Christian Petersen
Henning Ralf Stennicke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2003242506A1 publication Critical patent/AU2003242506A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003242506A 2002-07-12 2003-07-09 Tf antagonist Abandoned AU2003242506A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200201100 2002-07-12
DKPA200201100 2002-07-12
PCT/DK2003/000480 WO2004007557A2 (en) 2002-07-12 2003-07-09 Tf antagonist

Publications (1)

Publication Number Publication Date
AU2003242506A1 true AU2003242506A1 (en) 2004-02-02

Family

ID=30011020

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003242506A Abandoned AU2003242506A1 (en) 2002-07-12 2003-07-09 Tf antagonist

Country Status (2)

Country Link
AU (1) AU2003242506A1 (en)
WO (1) WO2004007557A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1587549A2 (en) * 2003-01-22 2005-10-26 Novo Nordisk A/S Radiolabelled tissue factor binding agent and the use thereof
WO2005025623A2 (en) * 2003-07-28 2005-03-24 Emory University Ef-24-factor vii conjugates
GB2419774A (en) 2004-10-27 2006-05-03 Ericsson Telefon Ab L M Accessing IP multimedia subsystem (IMS) services
UA109633C2 (en) 2008-12-09 2015-09-25 HUMAN ANTIBODY AGAINST TISSUE FACTOR
US8895497B2 (en) 2009-12-04 2014-11-25 Dcb-Usa, Llc Cathepsin S inhibitors
PT2582728T (en) * 2010-06-15 2017-11-23 Genmab As Human antibody drug conjugates against tissue factor
MX2016006488A (en) * 2013-11-21 2016-08-03 Genmab As Antibody-drug conjugate lyophilised formulation.
CA3010310C (en) 2016-01-15 2022-11-22 Rigshospitalet A positron-emitting 18-f labelled factor viia (fviia) imaging agent and method of use thereof
MA46864A (en) * 2016-11-17 2021-04-28 Minerva Imaging Aps FACTOR VII INHIBITED BY THE ACTIVE SITE MARKED BY 177-LU

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788965A (en) * 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
EP1150701A4 (en) * 1999-01-22 2003-03-26 Burnham Inst Homing pro-apoptotic conjugates and methods of using same
PT1198479E (en) * 1999-07-01 2008-08-12 Univ Yale Neovascular-targeted immunoconjugates
AU7270600A (en) * 1999-09-20 2001-04-24 Novo Nordisk A/S Bivalent inhibitor of fviia/tf/fxa complex
JP2001213804A (en) * 2000-01-31 2001-08-07 Chugai Pharmaceut Co Ltd Antitissue factor antibody complex

Also Published As

Publication number Publication date
WO2004007557A3 (en) 2004-04-22
WO2004007557A2 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2002951728A0 (en) Component interlocking
AU2002335152A1 (en) Robot-phone
AU2002952384A0 (en) Structures
WO2003072535A8 (en) Substituted hydroxyethylamines
AU2003238043A1 (en) Substituted imidazotriazines
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2003230395A1 (en) Micro-support structures
AU2003294900A1 (en) Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AU2003242506A1 (en) Tf antagonist
AU2003290818A1 (en) Topoisomerase-targeting agents
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2003264900A1 (en) Cast-cutter
AU2002318053A1 (en) Suplier
AU2002368348A1 (en) Electrosomatogram
AU2002348964A1 (en) Snowbike
AU2002341221A1 (en) Honey-brandy
AU2002344387A1 (en) Multifunction-pillow
AU2002100747A4 (en) Powersell
AU2002100468A4 (en) Flexi-edger
AU2002100655A4 (en) Armamulch
AU2002100957A4 (en) Sluggit
AU2002100482A4 (en) Tail-gate-ezy
AU2002100602A4 (en) Bonsystem

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase